Nombre de documents

16

CV de Patrick Chames


Article dans une revue16 documents

  • Thomas Krüwel, Damien Nevoltris, Julia Bode, Christian Dullin, Daniel Baty, et al.. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.. Scientific Reports, Nature Publishing Group, 2016, 6, pp.21834. <hal-01450793>
  • Marion Morgand, Mélanie Bouvin-Pley, Jean-Christophe Plantier, Alain Moreau, Elodie Alessandri, et al.. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1. Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2016, 71 (3), pp.237-245. <10.1097/QAI.0000000000000854>. <hal-01314296>
  • Damien Nevoltris, Benjamin Lombard, Elodie Dupuis, Gérard Mathis, Patrick Chames, et al.. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.. ACS Nano, American Chemical Society, 2015, 9 (2), pp.1388-99. <10.1021/nn505752u>. <hal-01450765>
  • Andrew M Prantner, Marc Turini, Brigitte Kerfelec, Shree Joshi, Daniel Baty, et al.. Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications.. Journal of Biomedical Nanotechnology, American Scientific Publishers, 2015, pp.1201-12. <hal-01450786>
  • Gilles Rousserie, Regina Grinevich, Kristina Brazhnik, Klervi Even-Desrumeaux, Brigitte Reveil, et al.. Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates.. Analytical Biochemistry, Elsevier Masson, 2015, 478, pp.26-32. <10.1016/j.ab.2015.02.029>. <hal-01450782>
  • Joanie Del Bano, Patrick Chames, Daniel Baty, Brigitte Kerfelec. Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?. Human Antibodies, IOS Press, 2015, 5 (1), <10.3390/antib5010001>. <hal-01450799>
  • Julie Matz, Cécile Hérate, Jérôme Bouchet, Nelson Dusetti, Odile Gayet, et al.. Selection of Intracellular Single-Domain Antibodies Targeting the HIV-1 Vpr Protein by Cytoplasmic Yeast Two-Hybrid System. PLoS ONE, Public Library of Science, 2014, 9 (12), pp.e113729. <10.1371/journal.pone.0113729>. <inserm-01093997>
  • Klervi Even-Desrumeaux, Patrick Fourquet, Véronique Secq, Daniel Baty, Patrick Chames. Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.: Single-domain antibodies for breast cancer diagnosis. Molecular BioSystems, Royal Society of Chemistry, 2012, 8 (9), pp.2385-2394. <10.1039/c2mb25063b>. <inserm-00722930>
  • Julie Matz, Pacal Kessler, Jérome Bouchet, Olivier Combes, Daniel Baty, et al.. Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120. Retrovirology, BioMed Central, 2012, 9 (Suppl 2), pp.P214. <inserm-00731772>
  • Priyamvada Acharya, Timothy Luongo, Julie Matz, Stephen Schmidt, Gwo-Yu Chuang, et al.. Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization. Retrovirology, BioMed Central, 2012, 9 (Suppl 2), pp.P346. <inserm-00731776>
  • Patrick Chames, Brigitte Kerfelec, Daniel Baty. Therapeutic antibodies for the treatment of pancreatic cancer.: Mabs against pancreatic cancer. TheScientificWorldJournal, TheScientificWorld, 2010, 10, pp.1107-20. <10.1100/tsw.2010.103>. <inserm-00497886>
  • Klervi Even-Desrumeaux, Daniel Baty, Patrick Chames. Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation.. Molecular BioSystems, Royal Society of Chemistry, 2010, 6 (11), pp.2241-8. <10.1039/c005279e>. <inserm-00521371>
  • Patrick Chames, Daniel Baty. [The future of antibody fragments, made of a single immunoglobulin domain.]. médecine/sciences, EDP Sciences, 2009, 25 (12), pp.1159-62. <inserm-00443810>
  • Ghislaine Behar, Patrick Chames, Isabelle Teulon, Amélie Cornillon, Faisal Alshoukr, et al.. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.. FEBS Journal, Wiley, 2009, 276 (14), pp.3881-93. <10.1111/j.1742-4658.2009.07101.x>. <hal-00420547>
  • Patrick Chames, Daniel Baty. Bispecific antibodies for cancer therapy: the light at the end of the tunnel?. mAbs, Taylor & Francis, 2009, 1 (6), pp.539-47. <inserm-00448211>
  • Ghislaine Behar, Sophie Sibéril, Agnès Groulet, Patrick Chames, Martine Pugnière, et al.. Isolation and characterization of anti-Fc{gamma}RIII (CD16) llama single-domain antibodies that activate natural killer cells.. Protein Engineering, Design and Selection, Oxford University Press (OUP), 2008, 21 (1), pp.1-10. <10.1093/protein/gzm064>. <hal-00258940>